| Jonathan Schneider, DO | |
|
4250 S Eason Blvd, Tupelo, MS 38801-6549 | |
| (662) 377-5265 | |
| (662) 377-5260 |
| Full Name | Jonathan Schneider |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 4250 S Eason Blvd, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730530064 | NPI | - | NPPES |
| 1730530064 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | 31487 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Mississippi Medical Center Services Llc | 6608048590 | 18 |
News Archive
Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR® (trospium chloride extended release capsules), an anticholinergic approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, predominantly to primary care physicians in the United States.
TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Ness Technologies, Inc., a global provider of information technology solutions and services, announced today that Ness, as the leader of a consortium with its partner Lynx, Ltd., has won a public tender with the Ministry of Health of the Slovak Republic to provide the first phase of an Electronic Healthcare Services system, valued at EUR32.4 million, or approximately $44 million, excluding VAT. The term of the initial phase is 24 months.
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic.
› Verified 8 days ago
| Entity Name | North Mississippi Medical Center Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013202886 PECOS PAC ID: 6608048590 Enrollment ID: O20111019000518 |
News Archive
Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR® (trospium chloride extended release capsules), an anticholinergic approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, predominantly to primary care physicians in the United States.
TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Ness Technologies, Inc., a global provider of information technology solutions and services, announced today that Ness, as the leader of a consortium with its partner Lynx, Ltd., has won a public tender with the Ministry of Health of the Slovak Republic to provide the first phase of an Electronic Healthcare Services system, valued at EUR32.4 million, or approximately $44 million, excluding VAT. The term of the initial phase is 24 months.
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Schneider, DO 4311 E Lohman Ave, Las Cruces, NM 88011-8255 Ph: (517) 917-5609 | Jonathan Schneider, DO 4250 S Eason Blvd, Tupelo, MS 38801-6549 Ph: (662) 377-5265 |
News Archive
Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR® (trospium chloride extended release capsules), an anticholinergic approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, predominantly to primary care physicians in the United States.
TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Ness Technologies, Inc., a global provider of information technology solutions and services, announced today that Ness, as the leader of a consortium with its partner Lynx, Ltd., has won a public tender with the Ministry of Health of the Slovak Republic to provide the first phase of an Electronic Healthcare Services system, valued at EUR32.4 million, or approximately $44 million, excluding VAT. The term of the initial phase is 24 months.
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic.
› Verified 8 days ago
Dr. Jeremy Caleb Adams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1211 S Gloster St Ste A, Tupelo, MS 38801 Phone: 662-767-4200 Fax: 662-767-4204 | |
Eric Van Lewis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste G1, Tupelo, MS 38801 Phone: 662-377-2663 Fax: 662-840-5856 | |
Dr. Taylor Phillips Mathis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1211 S Gloster St, Suite A, Tupelo, MS 38801 Phone: 662-767-4200 Fax: 662-767-4204 | |
Mr. Richard D. Rainey, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1211 South Gloster, Suite A, Tupelo, MS 38801 Phone: 662-767-4200 Fax: 662-767-4204 | |
Jeb Williams, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 499 S Gloster St Ste G1, Tupelo, MS 38801 Phone: 662-377-2663 | |
Dr. David Vecchione, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1211 S Gloster St Ste A, Tupelo, MS 38801 Phone: 662-767-4200 Fax: 662-767-4204 | |
Dr. George Karl Van Osten Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4381 South Eason Blvd., Suite 303, North Mississippi Sports Medicine And Orthopaedic Clini, Tupelo, MS 38801 Phone: 662-840-5747 Fax: 662-840-5856 |